Nasdaq · CIK 0001668397
MEDP Medpace Holdings, Inc.
Insider trading from SEC Form 4. Last filing 3 d ago. Close $612.05 on Oct 9, 2026, +56% from the 52-week low and -3% from the high.
Last 90 days
Net insider value
-$126M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
6
$126M by 1 insider
Insiders on file
11
with a Form 4 at this company
Price and insider trades, last year
MEDPOct 9, 2026 · close 612.05
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Medpace Holdings, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | August J. Troendle President & CEO sell | $30M 48,667 shares | -13% | +58% from low-1% from high | |
| 50Moderate | August J. Troendle President & CEO sell | $1.6M 2,564 shares | -1% | +57% from low-2% from high | |
| 55Moderate | August J. Troendle President & CEO sell | $27M 43,916 shares | -10% | +57% from low-2% from high | |
| 55Moderate | August J. Troendle President & CEO sell | $44M 70,901 shares | -14% | +59% from low0% from high | |
| 50Moderate | August J. Troendle President & CEO sell | $6.7M 10,880 shares | -2% | +56% from low-1% from high | |
| 50Moderate | August J. Troendle President & CEO sell | $15M 24,741 shares | -5% | +58% from low-0% from high | |
| 58Moderate | Susan E Burwig Exec. VP, Operations sell | $12M 20,000 shares | -42% | +123% from low0% from high | |
| 50Moderate | Kevin M. Brady CFO & Treasurer sell | $1.8M 3,000 shares | -33% | +113% from low-2% from high | |
| 65Notable | Susan E Burwig Exec. VP, Operations sell | $11M 18,000 shares | -27% | +117% from low-0% from high | |
| 53Moderate | Fred B Davenport Jr director sell | $3.5M 5,972 shares | -63% | +109% from low-4% from high | |
| 48Moderate | Susan E Burwig Exec. VP, Operations sell | $1.2M 2,000 shares | -3% | +115% from low-1% from high | |
| 53Moderate | Susan E Burwig Exec. VP, Operations sell | $4.8M 10,000 shares | -15% | +74% from low0% from high | |
| 65Notable | August J. Troendle CEO sell | $18M 37,393 shares | -4% | +72% from low-0% from high | |
| 54Moderate | August J. Troendle CEO sell | $295k 620 shares | -0% | +71% from low-1% from high | |
| 50Moderate | Cornelius P. McCarthy III director sell | $773k 1,662 shares | -14% | +67% from low-3% from high | |
| 60Notable | Susan E Burwig Exec. VP, Operations sell | $3.4M 7,500 shares | -12% | +63% from low-5% from high | |
| 60Notable | Stephen P Ewald General Counsel & Corp. Secy. sell | $1.4M 3,000 shares | -22% | +63% from low-5% from high | |
| 65Notable | August J. Troendle CEO sell | $22M 48,487 shares | -5% | +63% from low-5% from high | |
| 67Notable | Kevin M. Brady CFO & Treasurer sell | $5.5M 12,000 shares | -67% | +64% from low-5% from high | |
| 65Notable | Jesse J Geiger President sell | $19M 41,801 shares | -53% | +64% from low-5% from high | |
| 28Weak | Fred B Davenport Jr director sell | $517k 1,712 shares | -36% | +9% from low-18% from high | |
| 10Weak | Stephen P Ewald General Counsel & Corp. Secy. buy | $652 2 shares | +0% | - | |
| 30Weak | Brian T Carley director sell | $1.4M 4,003 shares | -13% | - |
Congressional trades
12 trades in MEDP disclosed by members of Congress under the STOCK Act. All congressional trades.
- David J. TaylorHouse · R-OH · last May 28, 20264 bought
2 sold - Gilbert Ray Cisneros, Jr.House · D-CA · last Feb 13, 20260 bought
3 sold - Lisa C. McClainHouse · R-MI · last Sep 12, 20251 bought
1 sold - Robert P. Bresnahan, Jr.House · R-PA · last Feb 13, 20250 bought
1 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
David J. Taylor House · R-OH | Purchase | MEDP Medpace Holdings, Inc. - Common Stock | $1,001 to $15k | May 15 / May 28 13 days after the trade | Clerk |
David J. Taylor House · R-OH | Purchase | MEDP Medpace Holdings, Inc. - Common Stock | $1,001 to $15k | May 15 / May 28 13 days after the trade | Clerk |
David J. Taylor House · R-OH | Purchase | MEDP Medpace Holdings, Inc. - Common Stock | $1,001 to $15k | Feb 26 / Mar 6 8 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Sale | MEDP Medpace Holdings, Inc. - Common Stock | $15k to $50k | Jan 15 / Feb 13 29 days after the trade | Clerk |
David J. Taylor House · R-OH | Sale | MEDP Medpace Holdings, Inc. - Common Stock | $1,001 to $15k | Jan 16 / Feb 2 17 days after the trade | Clerk |
David J. Taylor House · R-OH | Purchase | MEDP Medpace Holdings, Inc. - Common Stock | $1,001 to $15k | Jan 29 / Feb 2 4 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | MEDP Medpace Holdings, Inc. - Common Stock | $1,001 to $15k | Oct 9, 2025 / Nov 18, 2025 40 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Sale | MEDP Medpace Holdings, Inc. - Common Stock | $1,001 to $15k | Aug 4, 2025 / Sep 12, 2025 39 days after the trade | Clerk |
David J. Taylor House · R-OH | Sale | MEDP Medpace Holdings, Inc. - Common Stock | $1,001 to $15k | Jul 23, 2025 / Sep 2, 2025 41 days after the trade | Clerk |
Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | MEDP Medpace Holdings, Inc. - Common Stock | $1,001 to $15k | Jul 24, 2025 / Aug 14, 2025 21 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Purchase | MEDP Medpace Holdings, Inc. - Common Stock | $1,001 to $15k | Jul 22, 2025 / Aug 13, 2025 22 days after the trade | Clerk |
Robert P. Bresnahan, Jr. House · R-PA | Sale | MEDP Medpace Holdings, Inc. - Common Stock | $1,001 to $15k | Jan 13, 2025 / Feb 13, 2025 31 days after the trade | Clerk |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Susan E Burwig Exec. VP, Operations | MOption exercise Common Stock | +2,000 | $166.73 | $333k | 67,984 | 3 d ago |
| Oct 7, 2026 | Susan E Burwig Exec. VP, Operations | MOption exercise Employee Stock Option (Right to Buy)derivative | -2,000 | $0.00 | $0 | 6,028 | 3 d ago |
| Sep 30, 2026 | Cornelius P. McCarthy III director | MOption exercise Common Stock | +28 | - | - | 12,303 | 10 d ago |
| Sep 30, 2026 | Brian T Carley director | MOption exercise Common Stock | +36 | - | - | 27,861 | 10 d ago |
| Sep 30, 2026 | Robert O. Kraft director | MOption exercise Common Stock | +32 | - | - | 987 | 10 d ago |
| Sep 30, 2026 | Brian T Carley director | MOption exercise Restricted Stock Unitderivative | -36 | $0.00 | $0 | 35 | 10 d ago |
| Sep 30, 2026 | Cornelius P. McCarthy III director | MOption exercise Restricted Stock Unitderivative | -28 | $0.00 | $0 | 28 | 10 d ago |
| Sep 30, 2026 | Robert O. Kraft director | MOption exercise Restricted Stock Unitderivative | -32 | $0.00 | $0 | 32 | 10 d ago |
| Sep 29, 2026 | August J. Troendle President & CEO | SOpen-market sale Common Stock | -26,701 | $621.02 | $17M | 360,191 | 11 d ago |
| Sep 30, 2026 | August J. Troendle President & CEO | SOpen-market sale Common Stock | -21,966 | $625.47 | $14M | 338,225 | 11 d ago |
| Sep 25, 2026 | August J. Troendle President & CEO | SOpen-market sale Common Stock | -154 | $620.60 | $96k | 389,302 | 13 d ago |
| Sep 28, 2026 | August J. Troendle President & CEO | SOpen-market sale Common Stock | -2,410 | $620.07 | $1.5M | 386,892 | 13 d ago |
| Sep 23, 2026 | August J. Troendle President & CEO | SOpen-market sale Common Stock | -16,083 | $628.64 | $10M | 417,289 | 17 d ago |
| Sep 24, 2026 | August J. Troendle President & CEO | SOpen-market sale Common Stock | -27,833 | $621.33 | $17M | 389,456 | 17 d ago |
| Sep 21, 2026 | August J. Troendle President & CEO | SOpen-market sale Common Stock | -21,883 | $623.29 | $14M | 482,390 | 19 d ago |
| Sep 22, 2026 | August J. Troendle President & CEO | SOpen-market sale Common Stock | -49,018 | $628.11 | $31M | 433,372 | 19 d ago |
| Sep 17, 2026 | August J. Troendle President & CEO | SOpen-market sale Common Stock | -10,880 | $620.40 | $6.7M | 504,273 | 21 d ago |
| Sep 15, 2026 | Susan E Burwig Exec. VP, Operations | MOption exercise Common Stock | +3,000 | $166.73 | $500k | 65,984 | 25 d ago |
| Sep 15, 2026 | August J. Troendle President & CEO | SOpen-market sale Common Stock | -15,971 | $620.84 | $9.9M | 523,923 | 25 d ago |
| Sep 16, 2026 | August J. Troendle President & CEO | SOpen-market sale Common Stock | -8,770 | $621.29 | $5.4M | 515,153 | 25 d ago |
| Sep 15, 2026 | Susan E Burwig Exec. VP, Operations | MOption exercise Employee Stock Option (Right to Buy)derivative | -3,000 | $0.00 | $0 | 8,028 | 25 d ago |
| Dec 5, 2025 | Susan E Burwig Exec. VP, Operations | MOption exercise Common Stock | +10,000 | $107.93 | $1.1M | 47,500 | Dec 9, 2025 |
| Dec 5, 2025 | Susan E Burwig Exec. VP, Operations | MOption exercise Employee Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 10,984 | Dec 9, 2025 |
| Dec 2, 2025 | Susan E Burwig Exec. VP, Operations | MOption exercise Common Stock | +10,000 | $107.93 | $1.1M | 37,500 | Dec 4, 2025 |
| Dec 2, 2025 | Susan E Burwig Exec. VP, Operations | MOption exercise Employee Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 20,984 | Dec 4, 2025 |
| Nov 28, 2025 | Brian T Carley director | AGrant or award Restricted Stock Unitderivative | +143 | $592.46 | $85k | 143 | Dec 2, 2025 |
| Nov 24, 2025 | Susan E Burwig Exec. VP, Operations | SOpen-market sale Common Stock | -20,000 | $609.15 | $12M | 27,500 | Nov 26, 2025 |
| Nov 21, 2025 | Kevin M. Brady CFO & Treasurer | MOption exercise Common Stock | +3,000 | $166.73 | $500k | 9,000 | Nov 25, 2025 |
| Nov 21, 2025 | Kevin M. Brady CFO & Treasurer | SOpen-market sale Common Stock | -3,000 | $590.35 | $1.8M | 6,000 | Nov 25, 2025 |
| Nov 21, 2025 | Kevin M. Brady CFO & Treasurer | GGift Common Stock | -170 | $0.00 | $0 | 5,830 | Nov 25, 2025 |
| Nov 21, 2025 | Kevin M. Brady CFO & Treasurer | MOption exercise Employee Stock Option (Right to Buy)derivative | -3,000 | $0.00 | $0 | 0 | Nov 25, 2025 |
| Nov 11, 2025 | Susan E Burwig Exec. VP, Operations | SOpen-market sale Common Stock | -18,000 | $605.00 | $11M | 47,500 | Nov 12, 2025 |
| Oct 30, 2025 | Fred B Davenport Jr director | MOption exercise Common Stock | +6,472 | $54.99 | $356k | 9,470 | Nov 3, 2025 |
| Oct 30, 2025 | Fred B Davenport Jr director | SOpen-market sale Common Stock | -5,972 | $581.88 | $3.5M | 3,498 | Nov 3, 2025 |
| Oct 30, 2025 | Fred B Davenport Jr director | MOption exercise Stock Option (Right to Buy)derivative | -6,472 | $0.00 | $0 | 0 | Nov 3, 2025 |
| Oct 27, 2025 | Susan E Burwig Exec. VP, Operations | SOpen-market sale Common Stock | -2,000 | $605.01 | $1.2M | 65,500 | Oct 29, 2025 |
| Sep 30, 2025 | Brian T Carley director | MOption exercise Common Stock | +62 | - | - | 26,219 | Oct 2, 2025 |
| Sep 30, 2025 | Brian T Carley director | MOption exercise Restricted Stock Unitderivative | -62 | $0.00 | $0 | 62 | Oct 2, 2025 |
| Sep 26, 2025 | Susan E Burwig Exec. VP, Operations | MOption exercise Common Stock | +10,000 | $107.93 | $1.1M | 67,500 | Sep 30, 2025 |
| Sep 26, 2025 | Susan E Burwig Exec. VP, Operations | MOption exercise Employee Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 30,984 | Sep 30, 2025 |
| Sep 3, 2025 | Susan E Burwig Exec. VP, Operations | SOpen-market sale Common Stock | -10,000 | $480.00 | $4.8M | 57,500 | Sep 5, 2025 |
| Aug 29, 2025 | August J. Troendle CEO | SOpen-market sale Common Stock | -36,196 | $475.90 | $17M | 925,799 | Sep 3, 2025 |
| Sep 2, 2025 | August J. Troendle CEO | SOpen-market sale Common Stock | -1,197 | $475.11 | $569k | 924,602 | Sep 3, 2025 |
| Aug 27, 2025 | August J. Troendle CEO | SOpen-market sale Common Stock | -620 | $475.00 | $295k | 961,995 | Aug 28, 2025 |
| Aug 26, 2025 | Susan E Burwig Exec. VP, Operations | MOption exercise Common Stock | +10,000 | $107.93 | $1.1M | 67,500 | Aug 28, 2025 |
| Aug 26, 2025 | Susan E Burwig Exec. VP, Operations | MOption exercise Employee Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 40,984 | Aug 28, 2025 |
| Aug 19, 2025 | Cornelius P. McCarthy III director | SOpen-market sale Common Stock | -1,662 | $465.04 | $773k | 10,197 | Aug 21, 2025 |
| Jul 28, 2025 | Susan E Burwig Exec. VP, Operations | SOpen-market sale Common Stock | -7,500 | $450.14 | $3.4M | 57,500 | Jul 29, 2025 |
| Jul 28, 2025 | Stephen P Ewald General Counsel & Corp. Secy. | SOpen-market sale Common Stock | -3,000 | $450.00 | $1.4M | 10,343 | Jul 29, 2025 |
| Jul 28, 2025 | August J. Troendle CEO | SOpen-market sale Common Stock | -48,487 | $451.69 | $22M | 962,615 | Jul 29, 2025 |
| Jul 24, 2025 | Kevin M. Brady CFO & Treasurer | MOption exercise Common Stock | +12,000 | $57.94 | $695k | 18,000 | Jul 28, 2025 |
| Jul 24, 2025 | Jesse J Geiger President | MOption exercise Common Stock | +41,801 | $107.93 | $4.5M | 78,304 | Jul 28, 2025 |
| Jul 24, 2025 | Kevin M. Brady CFO & Treasurer | SOpen-market sale Common Stock | -12,000 | $454.23 | $5.5M | 6,000 | Jul 28, 2025 |
| Jul 24, 2025 | Jesse J Geiger President | SOpen-market sale Common Stock | -41,801 | $453.11 | $19M | 36,503 | Jul 28, 2025 |
| Jul 24, 2025 | Kevin M. Brady CFO & Treasurer | MOption exercise Employee Stock Option (Right to Buy)derivative | -12,000 | $0.00 | $0 | 0 | Jul 28, 2025 |
| Jul 24, 2025 | Jesse J Geiger President | MOption exercise Employee Stock Option (Right to Buy)derivative | -41,801 | $0.00 | $0 | 0 | Jul 28, 2025 |
| Jul 22, 2025 | Cornelius P. McCarthy III director | MOption exercise Common Stock | +1,972 | $54.99 | $108k | 11,859 | Jul 24, 2025 |
| Jul 22, 2025 | Cornelius P. McCarthy III director | MOption exercise Stock Option (Right to Buy)derivative | -1,972 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 18, 2025 | Cornelius P. McCarthy III director | MOption exercise Common Stock | +4,500 | $54.99 | $247k | 9,887 | Jul 22, 2025 |
| Jul 18, 2025 | Cornelius P. McCarthy III director | MOption exercise Stock Option (Right to Buy)derivative | -4,500 | $0.00 | $0 | 1,972 | Jul 22, 2025 |
| Jun 30, 2025 | Cornelius P. McCarthy III director | MOption exercise Common Stock | +50 | - | - | 5,387 | Jul 2, 2025 |
| Jun 30, 2025 | Brian T Carley director | MOption exercise Common Stock | +62 | - | - | 26,157 | Jul 2, 2025 |
| Jun 30, 2025 | Robert O. Kraft director | MOption exercise Common Stock | +57 | - | - | 776 | Jul 2, 2025 |
| Jun 30, 2025 | Robert O. Kraft director | MOption exercise Restricted Stock Unitderivative | -57 | $0.00 | $0 | 113 | Jul 2, 2025 |
| Jun 30, 2025 | Cornelius P. McCarthy III director | MOption exercise Restricted Stock Unitderivative | -50 | $0.00 | $0 | 98 | Jul 2, 2025 |
| Jun 30, 2025 | Brian T Carley director | MOption exercise Restricted Stock Unitderivative | -62 | $0.00 | $0 | 124 | Jul 2, 2025 |
| May 16, 2025 | Femida H. Gwadry-Sridhar director | AGrant or award Stock Option (Right to Buy)derivative | +1,224 | $0.00 | $0 | 1,224 | May 20, 2025 |
| May 16, 2025 | Dani S. Zander director | AGrant or award Stock Option (Right to Buy)derivative | +1,224 | $0.00 | $0 | 1,224 | May 20, 2025 |
| May 16, 2025 | Brian T Carley director | AGrant or award Stock Option (Right to Buy)derivative | +1,224 | $0.00 | $0 | 1,224 | May 20, 2025 |
| May 16, 2025 | Robert O. Kraft director | AGrant or award Stock Option (Right to Buy)derivative | +1,224 | $0.00 | $0 | 1,224 | May 20, 2025 |
| May 16, 2025 | Cornelius P. McCarthy III director | AGrant or award Stock Option (Right to Buy)derivative | +1,224 | $0.00 | $0 | 1,224 | May 20, 2025 |
| May 16, 2025 | Fred B Davenport Jr director | AGrant or award Stock Option (Right to Buy)derivative | +1,224 | $0.00 | $0 | 1,224 | May 20, 2025 |
| Apr 24, 2025 | Fred B Davenport Jr director | MOption exercise Common Stock | +4,710 | $57.17 | $269k | 4,710 | Apr 28, 2025 |
| Apr 24, 2025 | Fred B Davenport Jr director | SOpen-market sale Common Stock | -1,712 | $301.82 | $517k | 2,998 | Apr 28, 2025 |
| Apr 24, 2025 | Fred B Davenport Jr director | MOption exercise Stock Option (Right to Buy)derivative | -4,710 | $0.00 | $0 | 0 | Apr 28, 2025 |
| Mar 31, 2025 | Brian T Carley director | MOption exercise Common Stock | +63 | - | - | 26,095 | Apr 2, 2025 |
| Mar 31, 2025 | Robert O. Kraft director | MOption exercise Common Stock | +57 | - | - | 719 | Apr 2, 2025 |
| Mar 31, 2025 | Cornelius P. McCarthy III director | MOption exercise Common Stock | +50 | - | - | 5,337 | Apr 2, 2025 |
| Mar 31, 2025 | Brian T Carley director | MOption exercise Restricted Stock Unitderivative | -63 | $0.00 | $0 | 186 | Apr 2, 2025 |
| Mar 31, 2025 | Robert O. Kraft director | MOption exercise Restricted Stock Unitderivative | -57 | $0.00 | $0 | 170 | Apr 2, 2025 |
| Mar 31, 2025 | Cornelius P. McCarthy III director | MOption exercise Restricted Stock Unitderivative | -50 | $0.00 | $0 | 148 | Apr 2, 2025 |
| Mar 6, 2025 | Susan E Burwig Exec. VP, Operations | AGrant or award Employee Stock Option (Right to Buy)derivative | +11,017 | $0.00 | $0 | 11,017 | Mar 10, 2025 |
| Mar 6, 2025 | Kevin M. Brady CFO & Treasurer | AGrant or award Employee Stock Option (Right to Buy)derivative | +6,591 | $0.00 | $0 | 6,591 | Mar 10, 2025 |
| Mar 6, 2025 | Stephen P Ewald General Counsel & Corp. Secy. | AGrant or award Employee Stock Option (Right to Buy)derivative | +6,591 | $0.00 | $0 | 6,591 | Mar 10, 2025 |
| Mar 6, 2025 | Jesse J Geiger President | AGrant or award Employee Stock Option (Right to Buy)derivative | +9,886 | $0.00 | $0 | 9,886 | Mar 10, 2025 |
| Feb 27, 2025 | Stephen P Ewald General Counsel & Corp. Secy. | POpen-market purchase Common Stock | +2 | $326.11 | $652 | 13,343 | Feb 28, 2025 |
| Feb 24, 2025 | Brian T Carley director | MOption exercise Common Stock | +8,127 | $42.62 | $346k | 30,035 | Feb 26, 2025 |
| Feb 24, 2025 | Brian T Carley director | SOpen-market sale Common Stock | -4,003 | $345.59 | $1.4M | 26,032 | Feb 26, 2025 |
| Feb 24, 2025 | Brian T Carley director | MOption exercise Stock Option (Right to Buy)derivative | -8,127 | $0.00 | $0 | 0 | Feb 26, 2025 |
| Dec 31, 2024 | Brian T Carley director | MOption exercise Common Stock | +78 | - | - | 21,908 | Jan 3, 2025 |
| Dec 31, 2024 | Robert O. Kraft director | MOption exercise Common Stock | +71 | - | - | 662 | Jan 3, 2025 |
| Dec 31, 2024 | Brian T Carley director | MOption exercise Restricted Stock Unitderivative | -78 | $0.00 | $0 | 0 | Jan 3, 2025 |
| Dec 31, 2024 | Robert O. Kraft director | MOption exercise Restricted Stock Unitderivative | -71 | $0.00 | $0 | 0 | Jan 3, 2025 |
| Dec 6, 2024 | Jesse J Geiger President | MOption exercise Common Stock | +15,000 | $32.05 | $481k | 36,503 | Dec 10, 2024 |
| Dec 6, 2024 | Jesse J Geiger President | MOption exercise Employee Stock Option (Right to Buy)derivative | -15,000 | $0.00 | $0 | 0 | Dec 10, 2024 |
| Nov 29, 2024 | Brian T Carley director | AGrant or award Restricted Stock Unitderivative | +249 | $340.63 | $85k | 249 | Dec 3, 2024 |
| Nov 29, 2024 | Robert O. Kraft director | AGrant or award Restricted Stock Unitderivative | +227 | $340.63 | $77k | 227 | Dec 3, 2024 |
| Nov 29, 2024 | Cornelius P. McCarthy III director | AGrant or award Restricted Stock Unitderivative | +198 | $340.63 | $67k | 198 | Dec 3, 2024 |
| Nov 19, 2024 | Susan E Burwig Exec. VP, Operations | MOption exercise Common Stock | +7,500 | $32.05 | $240k | 65,000 | Nov 21, 2024 |
| Nov 19, 2024 | Susan E Burwig Exec. VP, Operations | MOption exercise Employee Stock Option (Right to Buy)derivative | -7,500 | $0.00 | $0 | 0 | Nov 21, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Susan E BurwigExec. VP, Operations
- Kevin M. BradyCFO & Treasurer
- Brian T Carleydirector
- Fred B Davenport Jrdirector
- Stephen P EwaldGeneral Counsel & Corp. Secy.
- Jesse J GeigerPresident
- Femida H. Gwadry-Sridhardirector
- Robert O. Kraftdirector, cfo, officer
- Cornelius P. McCarthy IIIdirector
- August J. TroendleCEO
- Dani S. Zanderdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.